Global X Russell 2000 Covered Call ETF holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Global X Russell 2000 Covered Call ETF RYLD
Morningstar’s Analysis RYLD
Will RYLD outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 98.9
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Global X Russell 2000 ETF | 100.64 | 1B | — |
Cash | 1.15 | 15M | Cash and Equivalents |
Warrant on Inhibrx Inc Ordinary Shares | 0.00 | 10,269 | — |
Warrant on Novartis AG Registered Shares | 0.00 | 10,157 | — |
Canadian Dollar | 0.00 | 5,030 | Cash and Equivalents |
Cartesian Therapeutics ([Wts/Rts]) 0% | 0.00 | 0 | — |
Omniab | 0.00 | 0 | — |
Omniab | 0.00 | 0 | — |
Rut Us 11/20/26 C2765 | −1.79 | −23M | — |